search
Back to results

Impacts of Oral Irrigation in Patients With Periimplant Mucositis

Primary Purpose

Peri-implant Mucositis

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Periimplant crevicular fluid (PICF) collection
Sponsored by
Ondokuz Mayıs University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Peri-implant Mucositis focused on measuring periimplant mucositis

Eligibility Criteria

45 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • subject with no systemic diseases that affect oral tissues and the nature of plaque,
  • with no professional cleaning for at least six months prior to baseline examination,
  • with one or more implants (Straumann, Waldenburg, Switzerland) functioning at least 24 months before the start of the study
  • having implants with BOP in at least two of the six regions
  • The people who agreed to refrain from the use of any nonstudy dental device or oral care product for the study duration were included in the study

Exclusion Criteria:

Exclusion criteria

  • subjects not cooperative,
  • having disease associated with bacteremia,
  • taking medication influencing gingival health (eg. dilantin, calcium channel blockers, cyclosporine, anticoagulants),
  • using long-term antibiotic and anti-inflammatory agents,
  • smokers and
  • women who were pregnant and in lactation period

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    Experimental

    Experimental

    Active Comparator

    Arm Label

    Oral irrigator group

    Interdental brush group

    Control group

    Arm Description

    Fifteen patients using toothbrush and oral irrigator(oxytet oral irrigatör).All patients were told to use Modified Bass method of tooth brushing technique. PI, GI, PPD and CAL values were measured with William's probe (Hu-Fried, Chicago, IL, A.B.D) around the teeth and with plastic probe around the implants. All clinical parameters were evaluated on each of the six regions of the implant (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual, disto-lingual).PICF was collected one day after the clinical examination from buccal aspects of the mesial and distal surfaces at the interproximal sites.Following the initial clinical records, all patients were performed full mouth instrumentation and described oral hygiene procedure according to their groups.

    Fifteen patients using toothbrush and interdental brush.All patients were told to use Modified Bass method of tooth brushing technique. PI, GI, PPD and CAL values were measured with William's probe (Hu-Fried, Chicago, IL, A.B.D) around the teeth and with plastic probe around the implants. All clinical parameters were evaluated on each of the six regions of the implant (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual, disto-lingual). PICF was collected one day after the clinical examination from buccal aspects of the mesial and distal surfaces at the interproximal sites. Following the initial clinical records, all patients were performed full mouth instrumentation and described oral hygiene procedure according to their groups.

    Fifteen patients using only toothbrush.All patients were told to use Modified Bass method of tooth brushing technique. PI, GI, PPD and CAL values were measured with William's probe (Hu-Fried, Chicago, IL, A.B.D) around the teeth and with plastic probe around the implants. All clinical parameters were evaluated on each of the six regions of the implant (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual, disto-lingual). PICF was collected one day after the clinical examination from buccal aspects of the mesial and distal surfaces at the interproximal sites. Following the initial clinical records, all patients were performed full mouth instrumentation and described oral hygiene procedure according to their groups.

    Outcomes

    Primary Outcome Measures

    Periimplant crevicular fluid level of IL-1β as a marker of gingival inflammation
    Elevated levels of IL-1β in periimplant crevicular fluid have been associated with the destructive changes that occur in the inflamed human gingiva
    Periimplant crevicular fluid level of TGF-β1 as a marker both of inflammatory phase and proliferative phase
    TGF-β1 plays a role in the development and progression of periodontal diseases.
    Periimplant crevicular fluid level of t-PA as a marker for clinical evaluation and efficacy of periodontal treatment
    Higher levels of t-PA in periimplant crevicular fluid have been associated with gingivitis and periodontitis.
    Periimplant crevicular fluid level of PAI-1 as a marker for clinical evaluation and efficacy of periodontal treatment
    Higher levels of PAI-1 may be associated with progression of periodontitis

    Secondary Outcome Measures

    Full Information

    First Posted
    February 6, 2019
    Last Updated
    February 15, 2019
    Sponsor
    Ondokuz Mayıs University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03844035
    Brief Title
    Impacts of Oral Irrigation in Patients With Periimplant Mucositis
    Official Title
    Clinical and Biochemical Evaluation of Oral Irrigation in Patients With Periimplant Mucositis
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    February 2019
    Overall Recruitment Status
    Completed
    Study Start Date
    November 6, 2014 (Actual)
    Primary Completion Date
    May 4, 2015 (Actual)
    Study Completion Date
    June 5, 2015 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Ondokuz Mayıs University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Product Manufactured in and Exported from the U.S.
    No

    5. Study Description

    Brief Summary
    The present study aimed to investigate clinically the cleaning effectiveness of different treatment modalities, that is, oral irrigator or interdental brush usage addition to routine brushing and examine TGF-β1, IL-1β, t-PA, and PAI-1 levels in periimplant crevicular fluid of patients with periimplant mucositis. The null hypothesis was that oral irrigators would be effective compared to interdental brush in the oral care of individuals who use implant-supported protheses.
    Detailed Description
    Detailed Description: Our aim was to evaluate efficacy of a manual tooth-brush with either interdental brush or oral irrigator in treatment of periimplant mucositis. Material and Method: Forty-five patients with periimplant mucositis having at least one implant (age range:45-60) were included in study. Study was planned as randomized, single-blind, parallel-design. Patients were divided into 3 equal groups; i)toothbrush+oral irrigator ii)toothbrush+interdental brush, iii)only toothbrush. After baseline examinations [Silness-Löe plaque index(PI), Löe-Silness gingival index(GI), probing pocket depth(PPD), clinical attachment level(CAL), bleeding on probing(BOP)], initial periodontal therapy was completed using full-mouth disinfection method. Periimplant crevicular fluid(PCF) were taken from patents to assess levels of interleukin-1beta(IL-1β), Transforming growth factor-beta(TGF- β), tissue-type plasminogen activator(t-PA), plasminogen activator inhibitor-1(PAI-1). Clinical records were repeated at 2, 4 and 12 weeks. The hypothesis of our study is that oral irrigators may be effective in oral care of individuals using an implant-supported prosthesis because of the ease of use.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Peri-implant Mucositis
    Keywords
    periimplant mucositis

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Forty-five patients with periimplant mucositis having at least one implant (age range:45-60) were included in study. Study was planned as randomized, single-blind, parallel-design. Patients were divided into 3 equal groups; i)toothbrush+oral irrigator ii)toothbrush+interdental brush, iii)only toothbrush. After baseline examinations [Silness-Löe plaque index(PI), Löe-Silness gingival index(GI), probing pocket depth(PPD), clinical attachment level(CAL), bleeding on probing(BOP)], initial periodontal therapy was completed using full-mouth disinfection method. Periimplant crevicular fluid(PCF) were taken from patents to assess levels of interleukin-1beta(IL-1β), Transforming growth factor-beta(TGF- β), tissue-type plasminogen activator(t-PA), plasminogen activator inhibitor-1(PAI-1). Clinical records were repeated at 2, 4 and 12 weeks.
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    45 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Oral irrigator group
    Arm Type
    Experimental
    Arm Description
    Fifteen patients using toothbrush and oral irrigator(oxytet oral irrigatör).All patients were told to use Modified Bass method of tooth brushing technique. PI, GI, PPD and CAL values were measured with William's probe (Hu-Fried, Chicago, IL, A.B.D) around the teeth and with plastic probe around the implants. All clinical parameters were evaluated on each of the six regions of the implant (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual, disto-lingual).PICF was collected one day after the clinical examination from buccal aspects of the mesial and distal surfaces at the interproximal sites.Following the initial clinical records, all patients were performed full mouth instrumentation and described oral hygiene procedure according to their groups.
    Arm Title
    Interdental brush group
    Arm Type
    Experimental
    Arm Description
    Fifteen patients using toothbrush and interdental brush.All patients were told to use Modified Bass method of tooth brushing technique. PI, GI, PPD and CAL values were measured with William's probe (Hu-Fried, Chicago, IL, A.B.D) around the teeth and with plastic probe around the implants. All clinical parameters were evaluated on each of the six regions of the implant (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual, disto-lingual). PICF was collected one day after the clinical examination from buccal aspects of the mesial and distal surfaces at the interproximal sites. Following the initial clinical records, all patients were performed full mouth instrumentation and described oral hygiene procedure according to their groups.
    Arm Title
    Control group
    Arm Type
    Active Comparator
    Arm Description
    Fifteen patients using only toothbrush.All patients were told to use Modified Bass method of tooth brushing technique. PI, GI, PPD and CAL values were measured with William's probe (Hu-Fried, Chicago, IL, A.B.D) around the teeth and with plastic probe around the implants. All clinical parameters were evaluated on each of the six regions of the implant (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual, disto-lingual). PICF was collected one day after the clinical examination from buccal aspects of the mesial and distal surfaces at the interproximal sites. Following the initial clinical records, all patients were performed full mouth instrumentation and described oral hygiene procedure according to their groups.
    Intervention Type
    Diagnostic Test
    Intervention Name(s)
    Periimplant crevicular fluid (PICF) collection
    Intervention Description
    Prior to PICF sampling, supragingival plaque was removed by sterile curets and, after air drying, the surfaces were isolated by cotton rolls. Filter paper strips (periopaper, proflow Inc., Amityville, New York, USA) were placed in sulcus for 30s. Care was taken not to avoid mechanical trauma and strips contaminated with blood or saliva were discarded. The absorbed PICF volume was estimated by a calibrated instrument (periotron 8000, proflow Inc., Amityville, NY, USA). Then, the strips were sealed into sterile tubes before freezing at -80⁰C. The readings were converted to an actual volume (µl) by reference to the standard curve.
    Primary Outcome Measure Information:
    Title
    Periimplant crevicular fluid level of IL-1β as a marker of gingival inflammation
    Description
    Elevated levels of IL-1β in periimplant crevicular fluid have been associated with the destructive changes that occur in the inflamed human gingiva
    Time Frame
    through study completion, an average of 1 year
    Title
    Periimplant crevicular fluid level of TGF-β1 as a marker both of inflammatory phase and proliferative phase
    Description
    TGF-β1 plays a role in the development and progression of periodontal diseases.
    Time Frame
    through study completion, an average of 1 year
    Title
    Periimplant crevicular fluid level of t-PA as a marker for clinical evaluation and efficacy of periodontal treatment
    Description
    Higher levels of t-PA in periimplant crevicular fluid have been associated with gingivitis and periodontitis.
    Time Frame
    through study completion, an average of 1 year
    Title
    Periimplant crevicular fluid level of PAI-1 as a marker for clinical evaluation and efficacy of periodontal treatment
    Description
    Higher levels of PAI-1 may be associated with progression of periodontitis
    Time Frame
    through study completion, an average of 1 year

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    45 Years
    Maximum Age & Unit of Time
    60 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: subject with no systemic diseases that affect oral tissues and the nature of plaque, with no professional cleaning for at least six months prior to baseline examination, with one or more implants (Straumann, Waldenburg, Switzerland) functioning at least 24 months before the start of the study having implants with BOP in at least two of the six regions The people who agreed to refrain from the use of any nonstudy dental device or oral care product for the study duration were included in the study Exclusion Criteria: Exclusion criteria subjects not cooperative, having disease associated with bacteremia, taking medication influencing gingival health (eg. dilantin, calcium channel blockers, cyclosporine, anticoagulants), using long-term antibiotic and anti-inflammatory agents, smokers and women who were pregnant and in lactation period
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Burcu OZKAN CETINKAYA, Prof
    Organizational Affiliation
    Ondokuzmayis University, Faculty of Dentistry, Department of Periodontology,
    Official's Role
    Study Director
    First Name & Middle Initial & Last Name & Degree
    Sema TUTUNCUOGLU, Dr
    Organizational Affiliation
    Samsun Oral and Dental Health Hospital, Samsun, Turkey
    Official's Role
    Principal Investigator
    First Name & Middle Initial & Last Name & Degree
    Ferda PAMUK, Assoc. Prof.
    Organizational Affiliation
    Beykent University, Faculty of Dentistry, Department of Periodontology
    Official's Role
    Study Chair
    First Name & Middle Initial & Last Name & Degree
    Bahattin AVCI, Assoc. Prof.
    Organizational Affiliation
    Ondokuzmayis University, Faculty of Medicine Department of Biochemistry
    Official's Role
    Study Chair
    First Name & Middle Initial & Last Name & Degree
    Gonca Cayir KELES, Prof
    Organizational Affiliation
    Okan University, Faculty of Dentistry, Department of Periodontology
    Official's Role
    Study Chair
    First Name & Middle Initial & Last Name & Degree
    Muge LUTFIOGLU, Assoc. Prof.
    Organizational Affiliation
    Ondokuzmayis University, Faculty of Dentistry, Department of Periodontology
    Official's Role
    Study Chair
    First Name & Middle Initial & Last Name & Degree
    Şevki GULER, Assist.Prof.
    Organizational Affiliation
    Izzet Baysal University, Faculty of Dentistry, Department of Periodontology
    Official's Role
    Study Chair

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    34251534
    Citation
    Tutuncuoglu S, Cetinkaya BO, Pamuk F, Avci B, Keles GC, Kurt-Bayrakdar S, Lutfioglu M. Clinical and biochemical evaluation of oral irrigation in patients with peri-implant mucositis: a randomized clinical trial. Clin Oral Investig. 2022 Jan;26(1):659-671. doi: 10.1007/s00784-021-04044-x. Epub 2021 Jul 12.
    Results Reference
    derived

    Learn more about this trial

    Impacts of Oral Irrigation in Patients With Periimplant Mucositis

    We'll reach out to this number within 24 hrs